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Fig 2. Histopathology of a biopsy specimen of the lower
ventral aspect of the arm. Glandlikemasses of gram-positive
cocci (arrows) typical of staphylococcal botryomycosis
were detected by Accustain Gram stain (Sigma, Steinheim,
Germany). (Original magnification:3100.)
J AM ACAD DERMATOL
OCTOBER 2014
e156 Letters(5 g) was administered intravenously to enhance
blood flow to the arm. Physiotherapy included
manual lymphatic drainage of the right arm. In
addition, compression bandages were applied to
prevent further self-manipulation. Altogether, these
treatments improved his skin condition.
Cutaneous botryomycosis is a chronic granulo-
matous bacterial skin infection characterized by
nodules, abscesses, and ulcers on the hands, feet,
genitals, and head.2 It primarily results from the
inoculation and persistent infection of injured skin3
by bacteria such as S aureus4 and Pseudomonas
aeruginosa. T cellerelated immune deficiency and
diabetes can promote the disease.2
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Calcific elastosis in the setting of weight gain
To the Editor: A 51-year-old man presented for
evaluation of stable, asymptomatic skin lesions
that had been present for several years. His
history was notable for Graves disease treated
with thyroidectomy, and significant ensuing weight
gain that predated the onset of his cutaneous
findings. The patient was otherwise healthy,
and his only prior medical treatment was levothy-
roxine. He was adopted and his family history was
unknown.
Physical examination revealed an overweight
man with asymptomatic hyperpigmented reticulated
plaques and longitudinal striae over his bilateral
flanks and legs (Fig 1). No other concerning
cutaneous lesions were present. A 4-mm punch
biopsy was performed of a right lower flank
hyperpigmented plaque. Hematoxylin-eosin and
elastic stains showed fragmented, mineralized elastic
fibers in the reticular dermis. Elastic fibers with
calcium deposition were present on von Kossa stain
(Fig 2).
The patient’s histologic examination, lesional
morphology, and lack of systemic symptoms sug-
gested a diagnosis of acquired calcific elastosis in the
setting of weight gain. The differential diagnosis also
included pseudoxanthoma elasticum (PXE), a rare
heritable disorder associated with defects of the
ABCC6 gene, causing progressive mineralization of
elastic fibers and complications of the skin, eye, and
cardiovascular system.1,2 Cutaneous lesions may be
the presenting sign; however, 85% of patients with
inherited PXE demonstrate angioid streaks, the
characteristic retinal findings resulting from breaks
in Bruch’s elastic membrane.3 Vascular involvement
is also common, manifesting as hemorrhage, inter-
mittent claudication, and/or hypertension.
PXE-like features have been reported in calci-
phylaxis and inflammatory conditions, including
lipodermatosclerosis, granuloma annulare, lichen
sclerosis, morphea profunda, erythema nodosum,
septal panniculitis, and nephrogenic systemic fibrosis.
More broadly, 4 major types of cutaneous calcification
exist—dystrophic, metastatic, idiopathic, and
Fig 2. Localized calcific elastosis. Histology of lesional
skin, right lower flank. A, Hematoxylin-eosin stain with
fragmented elastic fibers in the reticular dermis. B, von
Kossa stain revealing calcium deposition on dermal elastic
fibers. (Original magnifications: A, 340; B, 310.)
Fig 1. Localized calcific elastosis. Left flank with multiple
hyperpigmented reticulated plaques and longitudinal
striae.
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symptoms. Dystrophic calcinosis cutis, including that
of PXE and calcific elastosis, occurs in damaged or
inflamed skin secondary to mechanical, chemical, or
other factors; serum calcium and phosphate remain
within normal limits in such cases.4 Localized calcific
elastosis, although histologically indistinguishable
from PXE, is a distinct, often skin-limited entity.2 It is
most frequently described as lax, reticulated, or
cobble-stoned plaques often in the periumbilicalregion of obese multiparous women. Mechanical
stress, such as that of pregnancy and/or surgery,
with subsequent elastic fiber degeneration is thought
to produce localized disease.2,3 Calcific elastosis has
been reported in the setting of ascites, anasarca,
chronic renal failure, and tumefactive lipedema.2,5
Certain chemicals, such as Norwegian saltpeter
(calcium-ammonium-nitrate salts) fertilizer and peni-
cillamine have also been associated with calcific
elastosis.
To definitively rule out PXE, the patient
underwent ophthalmologic evaluation, cardiovas-
cular consultation, and routine health screening.
Molecular analysis of ABCC6 was not performed
in this case, in that these clinical evaluations
were all within normal limits.6 Localized calcific
elastosis has not been previously described
secondary to weight gain alone. As evidenced
by our findings, when confronted with cutaneous
elastic tissue abnormalities, it is important that
clinicians consider and pursue a comprehensive
diagnostic workup to rule out underlying sys-
temic involvement when appropriate for long-term
clinical management and counseling of affected
patients.
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http://dx.doi.org/10.1016/j.jaad.2014.06.034Fig 1. Scleromyxedema. Skin-colored subcutaneous nod-
ules on the forehead and eyelid edema.
Fig 2. Scleromyxedema. Photomicrograph of skin biopsy
specimen, showing pronounced deposit ofmucin associated
with increase in fibroblasts and collagen. (Hematoxylin-
eosin stain; original magnification:340.)Atypical scleromyxedema with prominent
nodular lesions associated with immune
thrombocytopenia: An unusual presentation
To the Editor: Scleromyxedema (SM) is a rare
cutaneous mucinosis that usually occurs with mono-
clonal gammopathy ([83.2%), predominantly an
IgG lambda subtype.1,2 SM may show a great variety
of extracutaneous manifestations ( gastrointestinal,
musculoskeletal, neurologic, pulmonary, cardiac,
and renal involvement) leading to significant
morbidity and mortality.1,2 We report a case of SM
with prominent scalp involvement, presence of
nodular lesions, and immune thrombocytopenia.
A 69-year-old woman presented with a 2-week
history of facial edema and progressive eruption.
The patient also reported severe scalp pruritus and
increased hair loss.
On physical examination, skin-colored firm pap-
ules, nodules, and edema of the face and both hands
were observed. The papules were initially located on
the scalp, neck, and back of the auricular area, then
gradually involved upper aspect of the trunk and the
surrounding skin showed scleroderma-like indura-
tion in these areas. Several nodules, 4 to 10 mm in
size, were present on the scalp, forehead (Fig 1), and
side portions of the chin.
Pathological examination of biopsy specimens
from a nodular scalp lesion and of a neck papule
(Fig 2) revealed an increase in fibroblasts, collagen,
and deposits of mucin in the papillary and mid-
reticular dermis. Laboratory analysis showed a pro-
gressive low platelet count (60-10 103/L, normal
range 150-400 103/L, platelet count within normal
limits 6 months earlier), with a normal peripheral
blood smear result and a normocellular bone
marrow with trilineage hematopoiesis. Serum pro-
tein electrophoresis, immunofixation electropho-
resis of serum and urine, and immunoglobulin free
light chain assays did not show paraproteinemia.
Other laboratory examination findings including
thyroid function were within normal limits and
autoantibody screening produced negative results.
Computed tomographic scans of the chest,
abdomen, and pelvis showed no relevant abnormal-
ities. Electromyography detected signs consistentwith a right carpal tunnel syndrome and peripheral
sensory and motor neuropathy. Based on clinical
manifestations, and histopathological and laboratory
data, the diagnosis of SM with a secondary immune
thrombocytopenia was made. The patient was
treated with 3 methylprednisolone pulses of 1 g,
followed by 1 mg/kg/d of prednisone for 1 month,
and intravenous immunoglobulins (2 g/kg per
cycle). Administration of a second course of intrave-
nous immunoglobulins, delivered after 4 weeks,
dramatically improved skin manifestations; however
persistence of low platelet count prompted the
addition of romiplostim, a thrombopoietin-receptor
agonist. The prescribed corticosteroids were gradu-
ally tapered off and romiplostim was withdrawn.
After 12 months of follow-up, she remains asymp-
tomatic and platelet count was within normal limits
